HEMODYNAMIC MONITORING SYSTEMS MARKET ANALYSIS

Hemodynamic Monitoring Systems Market, by Product Type (Vital Sign Monitors, Pulse Oximeters, Non-Invasive Blood Pressure Monitors, Central Venous Catheters, Pulmonary Artery Catheters), by Application (Invasive Hemodynamic Monitoring, Non-Invasive Hemodynamic Monitoring, Minimally Invasive Hemodynamic Monitoring), by End User (Hospitals, Clinics, Ambulatory Surgical Centers, Home Care Settings, Independent Catheterization Laboratories), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Published In : Nov 2022
Code : CMI1070
Pages :160
Formats :
Excel and PDF
Industry : Medical Devices

Market Challenges And Opportunities

Restraints

Increasing number of product recalls by regulatory authorities such as the U.S. Food and Drug Administration is the major factor that is expected to hinder growth of the global hemodynamic monitoring systems market. For instance, in January 2021, the U.S. Food and Drug Administration recalled class 2 device cogent hemodynamic monitoring system, which was manufactured by ICU Medical, Inc., a medical device company. The product was recalled due to a potential software issue in which the display had shown the incorrect continuous cardiac output (CCO) values after pulse Oximeters calibration.

Restaints